Press release
United States Respiratory Disorders Market Info 2025 | Top Companies - Regeneron Pharmaceuticals, Inc., Novartis AG, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd
Respiratory Disorders
DataM Intelligence has released its latest report on the "Respiratory Disorders Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.
United States: Recent Industry Developments
✅ October 2025: The FDA approved next-gen inhalers with smart sensors for COPD and asthma management.
✅ September 2025: Biopharma companies launched trials for gene therapy in rare pulmonary disorders.
✅ August 2025: Remote respiratory monitoring devices gained Medicare reimbursement expansion.
Japan: Recent Industry Developments
✅ October 2025: Japanese pharma firms advanced precision inhalation therapies with digital dose tracking.
✅ September 2025: R&D funding boosted studies on post-COVID chronic lung disease management.
✅ August 2025: AI-assisted spirometry devices entered clinical practice to improve early diagnosis.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/respiratory-disorders-market?kb
Latest FDA Approvals
FDA approved Jascayd (nerandomilast) tablets in 2025 for idiopathic pulmonary fibrosis, marking a new treatment option.
Precision Neuroscience's Layer 7 Cortical Interface for severe respiratory devices and neural control remains under evaluation, advancing regulatory pathways.
FDA's 2025 approvals also include first RNA-targeted treatments for hereditary angioedema impacting respiratory-related swelling.
Multiple companion diagnostics for respiratory disorders were cleared to support personalized treatment approaches
Key Market Highlights (Rephrased):
North America leads the respiratory disorders market, holding the largest revenue share of 43.57% in 2024.
The Asia Pacific region is the fastest-growing, expected to register a CAGR of 6.7% over the forecast period.
By disease type, the Chronic Obstructive Pulmonary Disease (COPD) segment dominated the market with a 37.09% revenue share in 2024.
Key Player:
GSK, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi, Regeneron Pharmaceuticals, Inc., Novartis AG, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd
Forecast Projection:
The global Respiratory Disorders market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.
Market Intelligence Research Process:
The Respiratory Disorders Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=respiratory-disorders-market?kb
Key Segments:
By Disease Type: (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Pneumonia, Cystic Fibrosis, Interstitial Lung Disease / Idiopathic Pulmonary Fibrosis, Tuberculosis, and Others)
By Treatment Type: (Therapeutics and Devices)
By End-User: (Hospitals, Specialty Clinics, Home Care Settings, and Others)
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/respiratory-disorders-market?kb
Latest M&A
Merck acquired UK-based Verona Pharma for $10 billion in 2025, strengthening its respiratory drug pipeline focused on COPD and chronic respiratory diseases.
ResMed acquired VirtuOx, a virtual respiratory diagnostics company, expanding its connected health solutions in respiratory care.
Philips Medisize expanded capabilities by acquiring Vectura, adding dry powder inhaler technology to its respiratory portfolio.
Sanofi agreed to acquire Vicebio, developing combination vaccines for respiratory viruses RSV and hMPV, expected to close in Q4 2025.
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/respiratory-disorders-market?kb
Reimbursement
Medicare enhanced reimbursement for home mechanical ventilators under new National Coverage Determination effective 2025, easing access.
Value-based reimbursement models reward improved chronic respiratory patient outcomes with remote monitoring and integrated care services.
Coverage increasingly supports multi-modality respiratory treatments pending clinical evidence and cost-effectiveness.
Challenges remain in reimbursement for emerging biologics and inhaled therapies, particularly in global markets
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Latest News
WHO/Europe report highlights over 80 million Europeans affected by chronic respiratory diseases, emphasizing underdiagnosis and poor management.
Advances in RNA-targeting therapies, such as Brensocatib for non-cystic fibrosis bronchiectasis, received FDA approval in 2025 as first-in-class treatments.
Growing adoption of telehealth and AI-enabled home respiratory monitoring is transforming chronic respiratory disease management.
Novel inhalation therapies targeting inflammation and airway remodeling are in late-stage trials, promising improved patient outcomes
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Respiratory Disorders Market Info 2025 | Top Companies - Regeneron Pharmaceuticals, Inc., Novartis AG, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd here
News-ID: 4257238 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Vegetable Proteins Market 2025: Industry Developments, Future Grow …
Global Vegetable Proteins Market reached US$ 11.2 billion in 2023 and is expected to reach US$ 23.1 billion by 2031, growing with a CAGR of 9.47% during the forecast period 2024-2031.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/vegetable-protein-market?sg
Industry Latest News 2025:
✅ 05/12/2025 - Danone announced it had entered into a definitive agreement to acquire a majority stake in Kate Farms (U.S. plant-based medical/everyday nutrition).
✅ 07/01/2025 - Danone completed the acquisition of…
United States Vegan Whipped Cream Market 2025: Industry Developments, Future Gro …
Global Vegan Whipped Cream Market reached USD 458.1 million in 2022 and is expected to reach USD 724.6 million by 2030, growing with a CAGR of 5.9% during the forecast period 2023-2030.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/vegan-whipped-cream-market?sg
Industry Latest News 2025:
✅ 07 Jul 2025 - Tate & Lyle showcased plant-based "mouthfeel" prototypes at IFT FIRST 2025, highlighting solutions used to make whippable/plant-based cream products.
✅ 2025 - Oatly's Whippable Creamy Oat…
Smart Hospitals Industry Insights 2025 | Digital Transformation, AI Adoption & F …
smart hospitals market size reached US$ 58.82 billion in 2024 is expected to reach US$ 230.94 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033
DataM Intelligence has released its latest report on the "Smart Hospitals Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging…
Japan Radio Frequency Identification (RFID) Market Outlook: Automation, Real-Tim …
Tokyo, Japan DataM Intelligence: The Japan Radio Frequency Identification (RFID) Market was valued at US$ 899.2 million in 2024 and is projected to reach US$ 2,408.2 million by 2030, growing at a CAGR of 18.2% during the forecast period (2025-2030). Japan remains one of the most dynamic RFID markets in the Asia-Pacific region, fueled by strong technological infrastructure, digital transformation initiatives, and the rapid expansion of smart logistics and retail…
More Releases for Respiratory
Prevalence Of Respiratory Diseases Fuels Demand For Respiratory Disposables: Key …
The Respiratory Disposables Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Respiratory Disposables Market Size During the Forecast Period?
The respiratory disposables market has seen rapid growth in recent years. It is expected to grow from $1.01 billion in 2024 to $1.15…
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market?
The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,…
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market?
The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,…
Molecular Respiratory Panels Market: Enhancing Accuracy and Speed in Respiratory …
Introduction
The global molecular respiratory panels market is rapidly evolving, driven by the need for faster, more accurate diagnostics in respiratory diseases. With respiratory infections and diseases becoming increasingly prevalent worldwide, accurate detection and timely diagnosis are critical to improving patient outcomes. Molecular respiratory panels, which utilize advanced molecular techniques like PCR (Polymerase Chain Reaction) and other nucleic acid-based methods, enable the rapid identification of pathogens responsible for respiratory conditions. These…
Tackling Respiratory Challenges: Lower Respiratory Tract Therapeutics Market 202 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Lower Respiratory Tract Therapeutics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $48.37 billion In…
Respiratory Assist Devices Market - Breathing Uninterrupted: Innovating Respirat …
Newark, New Castle, USA - new report, titled Respiratory Assist Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Respiratory Assist Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Respiratory Assist Devices market. The report offers an overview of…
